Table 1.
Mean ± SD | ||
---|---|---|
Age | 60.8 ± 14.9 | |
Sex | M | 22 (33.8%) |
F | 43 (66.2%) | |
WBC/ul | 7160 ± 1294 | |
N/L (ratio) | 2.68 ± 0.56 | |
History of embolization | 7 (10.8%) | |
Follow-up periods (months) | 97.7 ± 52.9 | |
Onset to treatment (months) | 4.77 ± 6.31 | |
Symptom/signs | Red eye | 60 (92.3%) |
Increases IOP | 26 (40%) | |
Cranial nerve palsy | 21 (32.7%) | |
Location of symptom | Right | 17 (26.2%) |
Left | 37 (56.9%) | |
Bilateral | 11 (16.9%) | |
Location of fistula | Right | 23 (35.4%) |
left | 26 (40%) | |
bilateral | 16 (24.6%) | |
Barrow classification | B | 4 (6.1%) |
C | 2 (3.1%) | |
D | 59 (90.8%) | |
Target volume (cc) | 2 ± 1.43 | |
Margin dose (Gy) | 18 ± 0.79 | |
Maximum dose (Gy) | 32.75 ± 3.65 | |
Maximum error in angiography (mm) | 0.12 ± 0.04 | |
Isodose line (%) | 55 ± 5.5 | |
Conformity index | 1.28 ± 0.08 | |
Number of isocenters | 5.4 ± 3.6 |
Data are presented as mean± standard deviation. N/L: neutrophil/lymphocyte.